Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

PURPOSE: The objective of this study was to estimate the risk of contralateral breast cancer in BRCA1 and BRCA2 carriers; and measure the extent to which host, family history, and cancer treatment-related factors modify the risk. PATIENTS AND METHODS: Patients were 810 women, with stage I or II brea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Metcalfe, K, Gershman, S, Lynch, H T, Ghadirian, P, Tung, N, Kim-Sing, C, Olopade, O I, Domchek, S, McLennan, J, Eisen, A, Foulkes, W D, Rosen, B, Sun, P, Narod, S A
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2011
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3101934/
https://ncbi.nlm.nih.gov/pubmed/21487411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.120
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars